Parameter | Parameter/ category | 7-days mortality (stepwise) | In-hospital mortalitya | ||||
---|---|---|---|---|---|---|---|
HR | CI95 | P-value | HR | CI95 | P-value | ||
Interaction effect between pathogen species and ESBL-production | E. coli ESBL-negative | 1 = Reference | 0.947 | 1 = Reference | 0.084 | ||
E. coli ESBL-positive | 1.16 | 0.70–1.90 | 0.571 | 1.22 | 0.88–1.68 | 0.228 | |
K. pneumoniae ESBL-negative | 0.98 | 0.64–1.50 | 0.926 | 1.39 | 1.07–1.82 | 0.015 | |
K. pneumoniae ESBL-positive | 1.05 | 0.49–2.27 | 0.894 | 1.01 | 0.60–1.67 | 0.983 | |
Comorbidities | Heart disease | 1.55 | 1.09–2.21 | 0.014 | 1.23 | 0.97–1.56 | 0.087 |
Liver disease | 1.96 | 1.40–2.74 | <0.001 | 1.85 | 1.48–2.30 | <0.001 | |
Renal disease | 2.86 | 1.99–4.10 | <0.001 | 2.32 | 1.82–2.95 | <0.001 | |
Cancer/ immunological disease | 1.66 | 1.21–2.28 | 0.002 | 1.58 | 1.28–1.95 | <0.001 |